Transdermal Estrogen Therapy Improves Gains in Skeletal Muscle Mass After 12 Weeks of Resistance Training in Early Postmenopausal Women

Women show an accelerated loss of muscle mass around menopause, possibly related to the decline in estrogen. Furthermore, the anabolic response to resistance exercise seems to be hampered in postmenopausal women. We aimed to test the hypothesis that transdermal estrogen therapy (ET) amplifies the sk...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in physiology Vol. 11; p. 596130
Main Authors Dam, Tine Vrist, Dalgaard, Line Barner, Ringgaard, Steffen, Johansen, Frank Ted, Bisgaard Bengtsen, Mads, Mose, Maike, Lauritsen, Katrine Meyer, Ørtenblad, Niels, Gravholt, Claus H, Hansen, Mette
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 18.01.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Women show an accelerated loss of muscle mass around menopause, possibly related to the decline in estrogen. Furthermore, the anabolic response to resistance exercise seems to be hampered in postmenopausal women. We aimed to test the hypothesis that transdermal estrogen therapy (ET) amplifies the skeletal muscle response to resistance training in early postmenopausal women. A double-blinded randomized controlled study. Department of Public Health, Aarhus University, Denmark. Thirty-one healthy, untrained postmenopausal women no more than 5 years past menopause. Supervised resistance training with placebo (PLC, = 16) or transdermal ET ( = 15) for 12 weeks. The primary outcome parameter was a cross-sectional area of quadriceps femoris measured by magnetic resonance imaging, and secondary parameters were fat-free mass (dual-energy X-ray absorptiometry), muscle strength, and functional tests. The increase in muscle cross-sectional area was significantly greater in the ET group (7.9%) compared with the PLC group (3.9%) ( < 0.05). Similarly, the increase in whole-body fat-free mass was greater in the ET group (5.5%) than in the PLC group (2.9%) ( < 0.05). Handgrip strength increased in ET ( < 0.05) but did not change in the PLC group. Muscle strength parameters, jumping height, and finger strength were all improved after the training period with no difference between groups. The use of transdermal ET enhanced the increase in muscle mass in response to 12 weeks of progressive resistance training in early postmenopausal women.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Reviewed by: Xu Yan, Victoria University, Australia; Ashril Yusof, University of Malaya, Malaysia
This article was submitted to Clinical and Translational Physiology, a section of the journal Frontiers in Physiology
Edited by: David Cameron-Smith, Singapore Institute for Clinical Sciences (A∗STAR), Singapore
ISSN:1664-042X
1664-042X
DOI:10.3389/fphys.2020.596130